Innoviva Forecast, price target & analysts
Innoviva Target price 2025 - Analyst rating & recommendation
Innoviva Classifications & Recommendation:
Innoviva Price Target
| Target Price | $35.70 |
| Price | $20.96 |
| Potential |
70.32%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Innoviva 2026 .
The average Innoviva target price is $35.70.
This is
70.32%
register free of charge
$57.75
175.52%
register free of charge
$17.17
18.08%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend Innoviva to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Innoviva stock has an average upside potential 2026 of
70.32%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 358.71 | 387.32 |
| 15.54% | 7.98% | |
| EBITDA Margin | 53.74% | 41.32% |
| 22.98% | 23.11% | |
| Net Margin | 6.52% | 22.97% |
| 88.74% | 252.27% |
7 Analysts have issued a sales forecast Innoviva 2025 . The average Innoviva sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Innoviva EBITDA forecast 2025. The average Innoviva EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Innoviva Analysts have issued a net profit forecast 2025. The average Innoviva net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.31 | 1.19 |
| 84.95% | 283.87% | |
| P/E | 17.61 | |
| EV/Sales | 3.33 |
7 Analysts have issued a Innoviva forecast for earnings per share. The average Innoviva EPS is
This results in the following potential growth metrics and future valuations:
Current Innoviva Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jul 11 2025 |
| Scotiabank |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Sep 30 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jul 11 2025 |
|
Locked
Scotiabank:
Locked
➜
Locked
|
Mar 07 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
